Two Sigma Investments, LP Provention Bio, Inc. Transaction History

Two Sigma Investments, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$6.7 - $24.21 $3.25 Million - $11.7 Million	-485,130 Reduced 82.11%	105,700 $2.55 Million
Q4 2022 Feb 14, 2023	BUY	$4.52 - $10.57 $1.95 Million - $4.56 Million	431,108 Added 269.91%	590,830 $6.25 Million
Q3 2022 Nov 14, 2022	BUY	$3.43 - $5.62 $342,982 - $561,971	99,995 Added 167.42%	159,722 $719,000
Q2 2022 Aug 15, 2022	BUY	$3.65 - $7.3 $157,413 - $314,827	43,127 Added 259.8%	59,727 $239,000
Q1 2022 May 16, 2022	BUY	$3.4 - $7.88 $56,440 - $130,808	16,600 New	16,600 $122,000
Q4 2021 Feb 14, 2022	SELL	$5.59 - $7.39 $523,224 - $691,704	-93,600 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.66 - $8.33 $322,620 - $474,810	57,000 Added 155.74%	93,600 $599,000
Q2 2021 Aug 16, 2021	SELL	$6.71 - $11.04 $3.36 Million - $5.53 Million	-500,720 Reduced 93.19%	36,600 $309,000
Q1 2021 May 17, 2021	BUY	$10.12 - $19.45 $1.5 Million - $2.89 Million	148,619 Added 38.23%	537,320 $5.64 Million
Q4 2020 Feb 16, 2021	SELL	$11.79 - $18.94 $1.91 Million - $3.06 Million	-161,631 Reduced 29.37%	388,701 $6.59 Million
Q3 2020 Nov 16, 2020	BUY	$10.34 - $15.2 $3.93 Million - $5.78 Million	379,956 Added 223.01%	550,332 $7.06 Million
Q2 2020 Aug 14, 2020	BUY	$7.81 - $17.0 $1.33 Million - $2.9 Million	170,376 New	170,376 $2.4 Million

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.